
Eltrog 50mg Tablet
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Eltrombopag (50mg)
Overview Eltrog 50mg Tablet
Eltrombopag 50mg tablets are indicated for the management of low platelet counts stemming from chronic immune thrombocytopenic purpura (ITP) or chronic hepatitis C (HCV). This medication also treats severe aplastic anemia. Acting as a thrombopoietin receptor agonist, Eltrombopag stimulates platelet production, thereby mitigating bleeding risk. Adhere strictly to your physician's prescribed dosage and regimen. It can be administered on an empty stomach and should be swallowed whole; avoid crushing, chewing, or breaking the tablet. Report any known drug allergies to your doctor. Commonly reported adverse effects include nausea, vomiting, diarrhea, upper respiratory infections, and urinary tract infections. Consult your physician if these side effects are troublesome; management strategies may be available. Prior to commencing treatment, disclose any pre-existing health conditions and all other medications you are currently using. Dose modifications may be necessary for patients with hepatic impairment; discuss this with your doctor.
Uses of Eltrog 50mg Tablet
Thrombocytopenia from immune thrombocytopenic purpura or hepatitis C; management of critical aplastic anemia
Major Benefits of Eltrog 50mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 50mg Eltrog tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Eltrog 50mg Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Eltrog 50mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. Administer Eltrog 50mg Tablet on an empty stomach.
How Eltrog 50mg Tablet works:
Proplatelet medication Eltrog (50mg tablets) promotes platelet production, thereby mitigating or preventing hemorrhaging. It achieves this effect through thrombopoietin receptor agonism.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Eltrog 50mg Tablet lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Eltrog 50mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Eltrog 50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Eltrog 50mg Tablet, which can induce dizziness and other side effects reducing alertness.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Eltrog 50mg tablets are considered safe, and no dosage modification is necessary. Nevertheless, disclosure of kidney disease to your physician is recommended. Routine monitoring of kidney function during treatment with this medication is advisable.
LiverCAUTION
Patients with liver impairment should use Eltrog 50mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Eltrog 50mg Tablet :
Omit any missed Eltrog 50mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Eltrog 50mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Biphenyl Derivatives |
| Developing Good Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Thrombopoietin receptor activator |
